Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by SquishyIncon Mar 03, 2017 2:19pm
116 Views
Post# 25928601

RE:RE:RE:RE:RE:RE:Trudeau announces legalization coming... stock barely moves?

RE:RE:RE:RE:RE:RE:Trudeau announces legalization coming... stock barely moves?I'm curious what your projected revenues are? Echelon is projecting 130 million in FY2018 and 280 million the year after based solely on domestic medical sales. It'd be great if you could share your breakdown of the numbers and your own projections.

SQCConsulting wrote: Not what I said...the technical say its a 2.60 stock but not the growth/market potential which is why it is being played so much (heavy volumes). So if it tanks , you lose virtually everything because its market cap is only 1.5 billion....could be a $30 sp but its only technically worth 2 and change now. Its way way way way way way way overvalued. Keep smoking the inventory though as the delusion of it becoming a big cap stock is what is making this a good play.


Bullboard Posts